Brief: Acorda Says Debtors Did Not Receive More Than One Qualified Bid Before Bid Deadline, In Connection With Chapter 11 Proceedings
04/06/2024 21:54
June 4 (Reuters) -
* ACORDA THERAPEUTICS- DEBTORS DID NOT RECEIVE MORE THAN
ONE
QUALIFIED BID BEFORE BID DEADLINE, IN CONNECTION WITH CHAPTER 11
PROCEEDINGS
* ACORDA THERAPEUTICS- PURSUANT TO COURT-APPROVED BID
PROCEDURES
MERZ PHARMACEUTICALS, LLC WAS DEEMED TO BE SUCCESSFUL BIDDER
* ACORDA THERAPEUTICS - ON MAY 29, CO AND SOME OF ITS UNITS
CANCELLED AUCTION
Source text for Eikon: ID:n0000950170-24-068750
Further company coverage: [ ]
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acorda Therapeutics
See all newsBrief: Acorda TherapeuticsCourt Held Hearing To Consider Approval Of Sale Of Substantially All Of Co's Assets To Merz Pharmaceuticals Under Asset Sale
Brief: Acorda Says Debtors Did Not Receive More Than One Qualified Bid Before Bid Deadline, In Connection With Chapter 11 Proceedings
Live Markets: Biotech companies in 'Darwinian' world as cash remains king
U.S. FDA declines to approve Supernus' drug-device combination for Parkinson's disease (updated)
U.S. FDA declines to approve Supernus' drug-device combination for Parkinson's disease